← Back to Search

Behavioral Intervention

Mindfulness Training for Type 1 Diabetes Anxiety

N/A

Recruiting

Research Sponsored by University of South Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Type 1 diabetes > 6 months

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial tests if mindfulness can reduce anxiety in teens with Type 1 diabetes.

Who is the study for?

This trial is for adolescents who have been living with Type 1 diabetes for more than six months, can read and speak English fluently, and are experiencing some anxiety as indicated by a GAD-7 score greater than five.Check my eligibility

What is being tested?

The study is testing a mobile health app that provides mindfulness training. The goal is to see if practicing mindfulness daily can help reduce anxiety symptoms in these young individuals with Type 1 diabetes.See study design

What are the potential side effects?

Mindfulness training typically does not involve physical side effects but may bring up emotional discomfort or distress as participants become more aware of their thoughts and feelings.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had Type 1 diabetes for more than 6 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Anxiety Symptoms

Secondary outcome measures

Diabetes-specific quality of life

Glycemic control

Trial Design

1Treatment groups

Experimental Treatment

Group I: Mindfulness training mobile health applicationExperimental Treatment1 Intervention

Use of a mindfulness training mobile health application

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Mindfulness training

2005

Completed Phase 3

~1860

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute of Nursing Research (NINR)NIH

580 Previous Clinical Trials

10,376,521 Total Patients Enrolled

University of South FloridaLead Sponsor

412 Previous Clinical Trials

187,019 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent has enrollment been completed for this medical experiment?

"Affirmative. Per the information on clinicaltrials.gov, this medical research is actively looking for participants since it was originally posted in October 1st of 2023 and its most recent update being November 14th of 2023. The trial has a quota of 40 patients to be enrolled from one site."

Answered by AI

Could senior citizens aged 75 or above join this experiment?

"According to the requisite qualifications for this trial, enrolment is restricted to individuals aged 12-19."

Answered by AI

Is it possible for me to join this medical research project?

"To be eligible to join this clinical trial, patients must have diagnosed anxiety and fall between the age range of 12 and 19 years old. The research team is hoping to recruit a total of 40 participants."

Answered by AI

Is enrollment for this trial still open?

"Indeed, the information available on clinicaltrials.gov points to active recruitment for this research project which was first advertised in October of 2023 and updated most recently in November. 40 potential participants can join from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Mindfulness Training in Adolescents With Type 1 Diabetes

2023. "Mindfulness Training in Adolescents With Type 1 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06140030.